Aura Biosciences Inc (AURA)
NASDAQ:AURA
US Market
Holding AURA?
Track your performance easily

Aura Biosciences Inc (AURA) Financial Statements

166 Followers

Aura Biosciences Inc Financial Overview

Aura Biosciences Inc's market cap is currently ―. The company's EPS TTM is $-1.791; its P/E ratio is -5.33; Aura Biosciences Inc is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.34M$ -19.66M$ -24.78M$ -18.51M$ -18.30M
EBITDA$ -20.02M$ -19.35M$ -24.46M-$ -18.00M
Net Income Common Stockholders$ -20.34M$ -19.71M$ -22.13M$ -18.51M$ -18.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 187.42M$ 202.87M$ 226.15M$ 149.06M$ 162.03M
Total Assets$ 218.28M$ 235.03M$ 255.07M$ 179.77M$ 192.74M
Total Debt$ 19.03M$ 19.32M$ 19.56M$ 20.19M$ 20.41M
Net Debt$ -168.38M$ -183.55M$ -206.59M$ -128.87M$ -141.62M
Total Liabilities$ 26.83M$ 26.24M$ 29.23M$ 28.05M$ 26.30M
Stockholders Equity$ 191.45M$ 208.78M$ 225.85M$ 151.72M$ 166.44M
Cash Flow-
Free Cash Flow$ -16.65M$ -24.54M$ -17.70M-$ -14.84M
Operating Cash Flow$ -16.13M$ -24.45M$ -17.39M$ -15.40M$ -14.64M
Investing Cash Flow$ 19.84M$ 9.40M$ -90.12M$ 21.63M$ 21.41M
Financing Cash Flow$ 83.00K$ 253.00K$ 92.98M$ 1.63M$ 2.48M
Currency in USD

Aura Biosciences Inc Earnings and Revenue History

Aura Biosciences Inc Debt to Assets

Aura Biosciences Inc Cash Flow

Aura Biosciences Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis